| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cambridge Equities, LP | 69% | $1,830,169,152 | 743,971,200 | Patrick Soon-Shiong | 10 Nov 2025 |
As of 30 Sep 2025, 258 institutional investors reported holding 149,650,186 shares of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX). This represents 14% of the company’s total 1,079,784,035 outstanding shares.
The largest institutional shareholders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 2.6% | 27,655,205 | +27% | 0% | $68,031,804 |
| BlackRock, Inc. | 1.8% | 19,810,963 | +12% | 0% | $48,734,970 |
| JANE STREET GROUP, LLC | 1.2% | 12,835,579 | +66% | 0.04% | $31,575,524 |
| STATE STREET CORP | 1% | 11,315,813 | +49% | 0% | $27,836,900 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.64% | 6,890,065 | +19% | 0% | $16,952,381 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 0.61% | 6,565,709 | 5.1% | $16,151,644 | |
| HEIGHTS CAPITAL MANAGEMENT, INC | 0.61% | 6,565,709 | 5.1% | $16,151,644 | |
| Woodline Partners LP | 0.49% | 5,297,725 | +54% | 0.06% | $13,032,404 |
| MORGAN STANLEY | 0.31% | 3,373,570 | +14% | 0% | $8,298,981 |
| AlphaCore Capital LLC | 0.28% | 2,988,544 | +0.46% | 0.25% | $7,351,818 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.24% | 2,642,654 | +43% | 0.01% | $6,500,929 |
| TWO SIGMA INVESTMENTS, LP | 0.24% | 2,607,860 | +225% | 0.01% | $6,415,336 |
| CITIGROUP INC | 0.22% | 2,381,999 | -4.2% | 0% | $5,859,718 |
| TANG CAPITAL MANAGEMENT LLC | 0.22% | 2,333,333 | 0% | 0.22% | $5,739,999 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 2,299,460 | +30% | 0% | $5,656,672 |
| NORTHERN TRUST CORP | 0.19% | 2,004,288 | +8.7% | 0% | $4,930,549 |
| UBS Group AG | 0.16% | 1,680,582 | +41% | 0% | $4,134,231 |
| BANK OF AMERICA CORP /DE/ | 0.15% | 1,654,776 | -81% | 0% | $4,070,749 |
| Skandinaviska Enskilda Banken AB (publ) | 0.12% | 1,324,871 | +348% | 0.01% | $3,245,934 |
| GROUP ONE TRADING LLC | 0.11% | 1,158,765 | +49% | 0.09% | $2,850,562 |
| GOLDMAN SACHS GROUP INC | 0.11% | 1,140,683 | +37% | 0% | $2,806,080 |
| CITADEL ADVISORS LLC | 0.1% | 1,130,748 | +44% | 0% | $2,781,641 |
| JPMORGAN CHASE & CO | 0.1% | 1,057,968 | -1.3% | 0% | $2,602,602 |
| RENAISSANCE TECHNOLOGIES LLC | 0.09% | 1,016,199 | 0% | $2,499,850 | |
| Squarepoint Ops LLC | 0.09% | 1,013,291 | 0.01% | $2,492,696 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,578,689 | $5,304,029 | +$300,402 | $1.98 | 34 |
| 2025 Q3 | 149,650,186 | $368,148,509 | +$61,433,165 | $2.46 | 258 |
| 2025 Q2 | 124,100,473 | $327,790,828 | +$117,120,227 | $2.64 | 236 |
| 2025 Q1 | 79,547,067 | $239,251,849 | -$5,452,987 | $3.01 | 205 |
| 2024 Q4 | 82,639,855 | $211,622,425 | +$33,803,467 | $2.56 | 193 |
| 2024 Q3 | 68,558,924 | $255,147,599 | +$21,750,911 | $3.72 | 172 |
| 2024 Q2 | 61,630,296 | $389,584,078 | -$21,451,973 | $6.32 | 188 |
| 2024 Q1 | 66,215,691 | $355,583,288 | +$50,300,460 | $5.37 | 157 |
| 2023 Q4 | 57,525,605 | $288,814,721 | +$55,491,609 | $5.02 | 141 |
| 2023 Q3 | 49,844,823 | $84,098,555 | +$17,530,681 | $1.69 | 128 |
| 2023 Q2 | 38,816,393 | $107,856,591 | -$8,601,646 | $2.78 | 108 |
| 2023 Q1 | 46,154,939 | $83,993,343 | -$34,886,181 | $1.82 | 141 |
| 2022 Q4 | 49,991,144 | $253,404,020 | +$54,026,855 | $5.07 | 134 |
| 2022 Q3 | 39,497,245 | $196,456,912 | +$32,509,458 | $4.97 | 117 |
| 2022 Q2 | 33,071,782 | $123,053,543 | -$11,174,770 | $3.72 | 124 |
| 2022 Q1 | 35,583,839 | $199,726,649 | +$5,888,206 | $5.61 | 135 |
| 2021 Q4 | 34,419,957 | $209,314,595 | +$13,197,046 | $6.08 | 127 |
| 2021 Q3 | 31,920,475 | $310,877,791 | +$41,850,403 | $9.74 | 118 |
| 2021 Q2 | 27,315,269 | $390,084,556 | +$155,924,275 | $14.28 | 115 |
| 2021 Q1 | 15,930,587 | $378,240,945 | +$377,213,945 | $23.74 | 112 |
| 2020 Q4 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q3 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q2 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q1 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q4 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q3 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q2 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q1 | 100 | $1,000 | $10.00 | 1 |